3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
15
Lymphoma, B-Cell, Marginal Zone
5
Neoplasms, Plasma Cell
3
Lymphoma
3
Recurrence
2
Pseudomyxoma Peritonei
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Infections
1
Helicobacter Infections
1
Chemotherapy Effect
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Cachexia
1
Appendiceal Neoplasms
1
Interventions
Voriconazole
2
Caspofungin
2
telavancin
1
monalizumab
1
fludarabine phosphate
1
fish oil triglycerides
1
avdoralimab
1
Whole-Body Irradiation
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Therapeutics
1
Tacrolimus
1
Standard of Care
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Observation
1
Methotrexate
1
Melphalan
1
Interferon-gamma
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Hematopoietic Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Daptomycin
1
Cyclophosphamide
1
Clarithromycin
1
Bevacizumab
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Infections
×
Clarithromycin
×
Clear all
NCT02624440
2015-12-08
SUTRICA
Aalborg University Hospital
Phase 2
Unknown
300 enrolled